FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to a therapeutic agent used against hepatitis C. Agent comprises compound of the formula (I) given in the invention claim description and pharmaceutical composition containing indicated compounds and inhibitor of hepatitis virus C polymerase. Compounds elicit the essentially enhanced activity as compared with the known ones. EFFECT: enhanced effectiveness and valuable medicinal properties of compounds. 33 cl, 218 tbl, 602 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES | 2006 |
|
RU2451009C2 |
| SUBSTITUTED DERIVATIVES OF 3-THIAZOLAMINEPROPIONIC ACID AND THEIR USE AS PHARMACEUTICALS | 2012 |
|
RU2617843C2 |
| AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2012 |
|
RU2605600C2 |
| ARYLALKYLCARBAMATE DERIVATIVES, SYNTHESIS AND USE THEREOF IN THERAPY | 2004 |
|
RU2400472C2 |
| HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2010 |
|
RU2558141C2 |
| NEW COMPOUNDS | 2007 |
|
RU2456273C2 |
| 1,3-DISUBSTITUTED 4-METHYL-1H-PYRROL-2-CARBOXAMIDES AND USE THEREOF FOR PREPARING DRUGS | 2007 |
|
RU2463294C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
